Fibrinogen and coronary risk
- 1 July 1999
- journal article
- review article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 1 (2) , 112-118
- https://doi.org/10.1007/s11886-999-0068-y
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Hemostasis in normotensive and hypertensive menJournal Of Hypertension, 1998
- Effects of hormone replacement therapies on fibrinogen and plasma viscosity in postmenopausal womenBritish Journal of Haematology, 1998
- Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery diseaseJournal of Internal Medicine, 1998
- A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study.Journal of Clinical Investigation, 1997
- Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)The American Journal of Cardiology, 1996
- Fibrinogen levels in women having coronary angiographyThe American Journal of Cardiology, 1996
- Intraindividual variability of fibrinogen levels and cardiovascular risk profile.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Changes in clot deformability— a possible explanation for the epidemiological association between plasma fibrinogen concentration and myocardial infarctionBlood Coagulation & Fibrinolysis, 1994
- Fibrin and Fibrinogen-Related Antigens in Patients with Stable and Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1987